Toggle Nav
mobile icon
My Cart
Close
  • Menu
  • Setting
  • Home
  • Signaling Pathways

Signaling Pathways

Items 41-50 of 80

Page
per page
  1. AUY922 (NVP-AUY922)
    A4057 AUY922 (NVP-AUY922)
     1 Citation
    Target: HSP90
    Summary: Potent Hsp90 inhibitor
      ≥23.27 mg/mL
  2. Geldanamycin
    A4060 Geldanamycin
     2 Citation
    Summary: Hsp90 inhibitor,potent and specific
      insoluble in EtOH; insoluble in H2O; ≥16.9 mg/mL
  3. IPI-504 (Retaspimycin hydrochloride)
    A4061 IPI-504 (Retaspimycin hydrochloride)
     3 Citation
    Target: HSP90
    Summary: Hsp90 inhibitor,novel, potent,selective
      ≥26.1 mg/mL
  4. NVP-BEP800
    A4064 NVP-BEP800
    Target: HSP90
    Summary: Oral Hsp90β inhibitor, novel, fully synthetic
  5. PF-04929113 (SNX-5422)
    A4065 PF-04929113 (SNX-5422)
    Target: HSP90
    Summary: Hsp90 inhibitor,potent and selective
      ≥23.85 mg/mL
  6. SNX-2112
    A4068 SNX-2112
     1 Citation
    Summary: Hsp90 inhibitor,ATP-competitve,potent and selective
      ≥23.05 mg/mL
  7. BMS-707035
    A4069 BMS-707035
    Target: HIV Integrases
    Summary: HIV-I integrase inhibitor,potent and specific
      insoluble in EtOH; insoluble in H2O; ≥41 mg/mL
  8. Fluorouracil (Adrucil)
    A4071 Fluorouracil (Adrucil)
     3 Citation
    Target: Thymidylate Synthase
    Summary: Antitumor agent;inhibitor of thymidylate synthase
      insoluble in EtOH; ≥10.04 mg/mL
  9. BIBR 953 (Dabigatran, Pradaxa)
    A4077 BIBR 953 (Dabigatran, Pradaxa)
    Summary: Thrombin inhibitor,potent,reversible and direct
      insoluble in DMSO; insoluble in EtOH; insoluble in H2O
  10. Danoprevir (RG7227)
    A4024 Danoprevir (RG7227)
    Target: HCV Proteases
    Summary: HCV NS3/4A protease inhibitor
      ≥32.6 mg/mL

Items 41-50 of 80

Page
per page
Relate Categories
Now Shopping by
  1. Category Proteases Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Category
  1. Caspase10item
  2. Aminopeptidase2item
  3. Calpains5item
  4. Cathepsin8item
  5. DPP-45item
  6. Elastase3item
  7. Gamma Secretase8item
  8. HCV Protease6item
  9. HSP13item
  10. HIV Integrase2item
  11. HIV Protease5item
  12. MMP7item
  13. Serine Protease2item
  14. Thrombin5item
  15. Other Proteases2item
Reversibility
  1. Reversible13item
  2. Irreversible7item
Target
  1. Caspases10item
  2. Proteasome1 item
  3. Cathepsins11item
  4. MMP6item
  5. Factor Xa2item
  6. Thymidylate Synthase1 item
  7. Aminopeptidases2item
  8. HSP9010item
  9. Notch1 item
  10. thrombin1 item
  11. Renin1 item
  12. HIV proteases1 item
  13. Pepsins1 item
  14. Calpains5item
  15. HCV Proteases3item
  16. Trypsins1 item
  17. Trypsin1 item
  18. Chymotrypsin1 item
  19. Kallikrein1 item
  20. Trypsinogen1 item
  21. HIV-1 gp1201 item
  22. HIV Integrases1 item
  23. Inward Rectifier Potassium (Kir) Channels1 item
  24. Papains1 item
  25. DPP-44item
  26. Nonstructural protein 5B (NS5B)1 item
  27. ADAMs1 item
  28. Dipeptidyl-peptidase II1 item
  29. HCV polymerase2item
  30. Elastases1 item
  31. NE1 item
Reported Experiments
  1. Animal Experiments70item
  2. Cell Experiments49item
Related Disease
  1. Acute Lung Injury1 item
  2. Acute Myeloid Leukemia1 item
  3. Breast Cancer11item
  4. Cancer31item
  5. Chronic Lymphocytic Leukemia1 item
  6. Clear Cell Renal Cell Carcinoma1 item
  7. Colon Cancer2item
  8. Diabetes2item
  9. Glioma1 item
  10. HCV3item
  11. Hepatitis C3item
  12. HIV1 item
  13. HIV Infections2item
  14. Inflammatory Diseases1 item
  15. Lung Cancer3item
  16. Lymphoma1 item
  17. Melanoma7item
  18. Multiple Myeloma2item
  19. Neuroblastoma1 item
  20. Non-small Cell Lung Cancer2item
  21. Osteoporosis1 item
  22. Ovarian Cancer4item
  23. Pancreatic Cancer3item
  24. Prostate Cancer3item
  25. Psoriasis1 item
  26. Renal Cell Carcinoma1 item
  27. Rheumatoid Arthritis3item
  28. Squamous Cell Carcinoma1 item
  29. Type 2 Diabetes1 item